The future of cancer care in the UK—time for a radical and sustainable National Cancer Plan
Authors:
- 14 November 2023
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 25 (1) , e6-e17
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trialThe Lancet Oncology, 2016
- Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990–2010: a longitudinal analysisThe Lancet, 2016
- Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared with hospital administration: results of a prospective single-center studyAnnals of Oncology, 2016
- Expanding global access to radiotherapy: the European Society for Radiotherapy and Oncology perspectiveThe Lancet Oncology, 2015
- Global cancer surgery: delivering safe, affordable, and timely cancer surgeryThe Lancet Oncology, 2015
- Data Resource Profile: Clinical Practice Research Datalink (CPRD)International Journal of Epidemiology, 2015
- Health-Related Quality of Life After Colorectal Cancer in England: A Patient-Reported Outcomes Study of Individuals 12 to 36 Months After DiagnosisJournal of Clinical Oncology, 2015
- Is community treatment best? a randomised trial comparing delivery of cancer treatment in the hospital, home and GP surgeryBritish Journal of Cancer, 2013
- Cancer diagnosis in primary careBritish Journal of General Practice, 2010
- Britain ranks poorly for cancer survival ratesBMJ, 1995